Trial · NCT03127956
Adverse events17
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 17 of 17
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Application site dryness | General disorders | Olumacostat Glasaretil Gel, 5.0% | 28 | 741 | |
| other | Application site erythema | General disorders | Olumacostat Glasaretil Gel, 5.0% | 25 | 741 | |
| other | Application site pain | General disorders | Olumacostat Glasaretil Gel, 5.0% | 29 | 741 | |
| other | Application site pruritus | General disorders | Olumacostat Glasaretil Gel, 5.0% | 39 | 741 | |
| other | Influenza | Infections and infestations | Olumacostat Glasaretil Gel, 5.0% | 16 | 741 | |
| other | Nasopharyngitis | Infections and infestations | Olumacostat Glasaretil Gel, 5.0% | 49 | 741 | |
| other | Upper respiratory tract infection | Infections and infestations | Olumacostat Glasaretil Gel, 5.0% | 57 | 741 | |
| other | Sunburn | Injury, poisoning and procedural complications | Olumacostat Glasaretil Gel, 5.0% | 19 | 741 | |
| other | Headache | Nervous system disorders | Olumacostat Glasaretil Gel, 5.0% | 19 | 741 | |
| serious | Infectious mononucleosis | Infections and infestations | Olumacostat Glasaretil Gel, 5.0% | 1 | 741 | |
| serious | Urinary tract infection | Infections and infestations | Olumacostat Glasaretil Gel, 5.0% | 1 | 741 | |
| serious | Ankle fracture | Injury, poisoning and procedural complications | Olumacostat Glasaretil Gel, 5.0% | 1 | 741 | |
| serious | Epilepsy | Nervous system disorders | Olumacostat Glasaretil Gel, 5.0% | 1 | 741 | |
| serious | Depression | Psychiatric disorders | Olumacostat Glasaretil Gel, 5.0% | 1 | 741 | |
| serious | Suicidal ideation | Psychiatric disorders | Olumacostat Glasaretil Gel, 5.0% | 1 | 741 | |
| serious | Nephrolithiasis | Renal and urinary disorders | Olumacostat Glasaretil Gel, 5.0% | 1 | 741 | |
| serious | Hypertension | Vascular disorders | Olumacostat Glasaretil Gel, 5.0% | 1 | 741 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03127956/events